Drug Profile
Diphtheria and tetanus vaccine - Zydus Lifesciences
Alternative Names: Diphtheria-tetanus vaccine - Zydus Lifesciences; DT vaccine - Zydus LifesciencesLatest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Cadila Healthcare
- Developer Zydus Lifesciences
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diphtheria; Tetanus
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for phase-I development in Diphtheria(Prevention, In volunteers, In adults) in India (IM)
- 28 Jul 2022 No recent reports of development identified for phase-I development in Tetanus(Prevention, In volunteers, In adults) in India (IM)
- 29 Jul 2020 Vaccine is still in phase I trial for Diphtheria and Tetanus in India (CTRI/2020/06/026086)